Alert: Federal Executive Order Signed to Accelerate Psychedelic Research and Access

President Trump has signed an executive order directing federal agencies to accelerate psychedelic research and improve access. This order aims to reduce bureaucratic hurdles for studies involving psychedelics and allocate $50M in match-funding via ARPA-H for state investments, potentially streamlining future product development and market access.

President Trump signed an executive order to accelerate psychedelic research and access across the U.S. government. The order directs agencies to reduce bureaucratic barriers for conducting studies with psychedelics and allocates initial match-funding of $50M through the Advanced Research Projects Agency for Health (ARPA-H) for state-level psychedelic research programs. This move signals a significant push from the White House to streamline the path for new psychedelic therapies and potentially impact future regulatory landscapes.

Sentinel Insight